Ghasem Solgi | Microbiology | Best Researcher Award

Prof. Ghasem Solgi | Microbiology | Best Researcher Award

Professor of Immunology from Hamadan University of Medical Sciences, Iran

Dr. Ghasem Solgi is a seasoned medical immunologist with extensive experience in both academic and clinical research settings. Born in 1976 in Iran, he has dedicated over two decades to advancing the field of immunology, particularly in transplantation and immunogenetics. As the Head of the Immunogenetics Lab at Hamadan University of Medical Sciences, Dr. Solgi has played a pivotal role in shaping research in HLA-related immunology and autoimmune diseases. His research primarily investigates the role of HLA genes in disease susceptibility, treatment response, and transplant outcomes, contributing valuable insights to clinical immunology. Dr. Solgi’s leadership experience, including his tenure as Deputy for Research Affairs and Head of the Immunology Department, reflects his commitment to both scientific inquiry and academic governance. He has mentored numerous graduate and postgraduate students, actively participates in peer review for high-impact journals, and maintains membership in respected scientific societies. His multidisciplinary approach, which bridges immunogenetics, autoimmune diseases, and clinical transplant immunology, underscores the translational impact of his work. With an impressive history of scientific supervision and collaboration, Dr. Solgi continues to contribute to the global immunology community through both innovative research and the nurturing of future scholars.

Professional Profile

Education

Dr. Ghasem Solgi holds a strong academic foundation in medical immunology, shaped by rigorous training at renowned institutions. He earned his Ph.D. in Medical Immunology from Tehran University of Medical Sciences in 2009. His doctoral thesis focused on the effects of donor bone marrow cell infusion on microchimerism and allograft outcomes in kidney transplant patients, followed by a comprehensive five-year follow-up study—highlighting his early dedication to transplantation immunology. Prior to his doctoral studies, Dr. Solgi completed his M.Sc. in Medical Immunology at Isfahan University of Medical Sciences in 2002. His master’s thesis compared serological and DNA-based methods for HLA typing in kidney allograft recipients, laying the groundwork for his long-standing focus on HLA research. Further enriching his expertise, he undertook a practical course and thesis completion in Transplantation Immunology at IKT in Ulm, Germany, during 2008–2009. This international experience not only refined his technical skills but also exposed him to diverse scientific environments. Dr. Solgi’s educational trajectory demonstrates a consistent commitment to excellence in immunology, emphasizing both theoretical knowledge and hands-on laboratory experience. His academic preparation has been instrumental in shaping his career as a researcher, educator, and clinical immunology expert.

Professional Experience

Dr. Ghasem Solgi has accumulated a wealth of professional experience in academia and research since earning his doctoral degree. He currently serves as the Head of the Immunogenetics Lab in the Immunology Department at Hamadan University of Medical Sciences, a role he has held since 2020. From 2016 to 2020, he was the Deputy for Research Affairs of the Medical School, where he contributed to strategic planning and research development. Previously, between 2015 and 2019, he served as the Head of the Immunology Department at the same institution, reflecting his leadership capabilities and influence on departmental growth. Earlier in his career, Dr. Solgi worked as an Assistant Professor in the Immunology Department at Hamadan University (2012–2015) and Ahvaz Jundishapur University of Medical Sciences (2009–2012). These academic roles have allowed him to balance research, teaching, and mentorship, while advancing the university’s immunology programs. His career path demonstrates a steady progression of leadership in both scientific and administrative capacities. Through his sustained involvement in immunogenetics and autoimmune research, Dr. Solgi has cultivated a distinguished profile, earning respect from colleagues, students, and collaborators alike.

Research Interests

Dr. Ghasem Solgi’s research interests lie primarily in the field of immunogenetics and transplantation immunology, with a particular focus on the Human Leukocyte Antigen (HLA) system and its relationship to disease pathogenesis and therapeutic outcomes. His studies aim to understand how genetic and immunological factors influence immune responses in organ transplantation and autoimmune disorders. Specifically, he investigates the distribution of HLA alleles and haplotypes in diseases such as type 1 diabetes (T1D), multiple sclerosis (MS), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and their correlation with susceptibility, disease severity, and treatment response. Dr. Solgi has also examined the role of HLA in COVID-19, exploring genetic predisposition to disease severity. His transplantation research includes microchimerism analysis, anti-HLA antibody detection, and long-term survival of kidney transplant patients. These interdisciplinary topics combine clinical relevance with molecular insights, aiming to improve diagnosis, prognosis, and personalized treatment strategies. His dedication to integrating immunogenetic data with clinical outcomes has placed his research at the intersection of translational medicine and precision immunology. This comprehensive scope not only addresses pressing healthcare challenges but also contributes to evolving strategies in immunotherapy and transplant compatibility assessment.

Research Skills

Dr. Ghasem Solgi possesses a robust set of research skills that span molecular biology, immunogenetics, and clinical immunology. He has extensive expertise in HLA typing using both serological and DNA-based methods, which he applied early in his career and further developed through practical training in Germany. His technical proficiency includes flow cytometry, ELISA, PCR-based genotyping, and microchimerism analysis—essential tools for studying immune responses in transplant recipients and autoimmune patients. Dr. Solgi is skilled in study design, biostatistical analysis, and survival analysis, which are critical in assessing long-term patient outcomes in kidney transplantation. He is also experienced in conducting family-based genetic studies to evaluate allelic distribution in disease populations. His ability to integrate laboratory findings with clinical parameters demonstrates a high level of translational research competency. In addition, Dr. Solgi’s editorial contributions to numerous international journals reflect his critical appraisal skills and deep understanding of current scientific methodologies. His mentoring record further showcases his ability to transfer knowledge and guide complex research projects, making him not only a proficient investigator but also a collaborative academic leader in immunology and genetic research.

Awards and Honors

While specific awards are not explicitly listed in the available documentation, Dr. Ghasem Solgi’s professional trajectory and academic appointments reflect significant recognition and respect within the scientific community. His leadership roles—such as Head of the Immunogenetics Lab, Head of the Immunology Department, and Deputy for Research Affairs—demonstrate institutional trust and acknowledgment of his scientific contributions. Additionally, his long-standing memberships in prominent organizations such as the Iranian Society of Immunology and Allergy (since 2006) and the European Federation for Immunogenetics (since 2010) further signify professional standing. Dr. Solgi’s participation as a manuscript reviewer for more than a dozen respected journals, including Scientific Reports, Journal of Clinical Medicine, Human Immunology, and Diagnostics, underscores his expertise and influence in shaping contemporary immunological research. These editorial responsibilities are a form of professional recognition typically granted to well-established researchers. His record of supervising graduate and postgraduate students also reflects academic confidence in his mentorship and leadership. While formal awards could be added to enhance visibility, Dr. Solgi’s contributions, impact, and peer acknowledgment position him as a highly respected figure in his field.

Conclusion

Dr. Ghasem Solgi is a highly accomplished immunologist whose work bridges fundamental research and clinical application, particularly in the areas of transplantation immunology and immunogenetics. With an educational background grounded in top-tier Iranian institutions and complemented by international training, he has consistently demonstrated academic rigor and scientific curiosity. His professional roles across two leading Iranian universities, combined with his leadership of research labs and departments, reveal a strong commitment to advancing medical science and nurturing future experts. Dr. Solgi’s research has yielded valuable insights into the HLA system’s role in autoimmune diseases and transplant outcomes, contributing to the development of more effective diagnostic and therapeutic strategies. He possesses strong technical and analytical research skills, and his involvement in numerous peer-reviewed journals speaks to his academic credibility. Although additional international awards or collaborations would further elevate his profile, the depth and impact of his work firmly establish him as a deserving nominee for the Best Researcher Award. Dr. Solgi’s enduring contributions to immunology, combined with his leadership and mentorship, make him a vital asset to both the academic community and the broader field of clinical research.

Publications Top Notes

  1. Chemical Contamination in the Extracted DNA Affects the Results of HLA Typing by the PCR-SSOP Method

  • Authors: A. Shirizadeh, M. Ebrahimpur, S. Soltani, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2025

  • Citations: 2

  1. A Potential Link Between HLA-DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients

  • Authors: A. Tahamoli-Roudsari, A. Rasouli-Saravani, Z. Basiri, M. Hajilooei, G. Solgi

  • Journal: International Journal of Immunogenetics

  • Year: 2025

  1. Potential Contribution of Gut Microbiota in the Development of Autoantibodies in T1D Children Carrying HLA-DRB1/DQB1 Risk Alleles: An Experimental and In Silico Analysis

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  • Citations: 1

  1. MicroRNA -21 Expression as an Auxiliary Diagnostic Biomarker of Acute Brucellosis

  • Authors: M. Rezaeepoor, F. Keramat, S. Jourghasemi, M. Hajilooei, G. Solgi

  • Journal: Molecular Biology Reports

  • Year: 2024

  1. Peripheral Blood Mononuclear Cells Show Markers of Mitochondrial Dysfunction in Rheumatoid Arthritis

  • Authors: A. Abbasifard, G. Solgi, I. Khodadadi, H. Tayebinia, A. Fazaeli

  • Journal: Cell Biochemistry and Function

  • Year: 2024

  • Citations: 1

  1. Determination of HLA Class II Risk Alleles and Prediction of Self/Non-Self-Epitopes Contributing Hashimoto’s Thyroiditis in a Group of Iranian Patients

  • Authors: A. Shirizadeh, S. Borzouei, Z. Razavi, J. Faradmal, G. Solgi

  • Journal: Immunogenetics

  • Year: 2024

  1. Family-Based Association of HLA-DRB1 and DQB1 Alleles and Haplotypes in a Group of Iranian Type 1 Diabetes Children

  • Authors: A. Shirizadeh, Z. Razavi, V. Saeedi, G.E. Morahan, G. Solgi

  • Journal: HLA

  • Year: 2024

  • Citations: 3

  1. Epigenetic Regulation of FOXP3 Gene Expression in Relation to Impaired Function of Regulatory T Cells in Systemic Lupus Erythematosus

  • Authors: P. Fakour, A. Shirizadeh, A. Tahamoli-Roudsari, G. Solgi

  • Journal: Not specified

  • Citations: 1

 

Silas Awuor | Immunology and Microbiology | Best Researcher Award

Dr. Silas Awuor | Immunology and Microbiology | Best Researcher Award

Silas Onyango Awuor is a highly skilled and accomplished professional known for his expertise in the field of environmental science, sustainable development, and climate change. With a deep commitment to addressing the pressing issues surrounding the environment, Awuor has demonstrated an exceptional ability to work on interdisciplinary projects aimed at improving the balance between human activities and the ecosystem. Over the years, he has collaborated with multiple international organizations, contributed to policy development, and led research initiatives in the areas of environmental protection, climate adaptation, and community development. His approach combines scientific rigor with practical solutions, making a notable impact on the global dialogue surrounding sustainability and environmental responsibility.

Professional Profile

Education

Silas Onyango Awuor pursued his higher education in the field of environmental science and related disciplines, gaining an in-depth understanding of ecological dynamics, environmental policy, and sustainable development. His academic background includes degrees from reputable institutions, where he acquired a blend of theoretical knowledge and practical skills. Awuor’s educational journey laid the foundation for his continued contributions to environmental research and policy. Through rigorous coursework and research, he has gained expertise in ecological assessments, environmental monitoring techniques, and the social dimensions of environmental challenges. His educational experience has been pivotal in shaping his current research and professional endeavors.

Professional Experience

Throughout his career, Silas Onyango Awuor has held various professional roles that emphasize his leadership in environmental research and policy development. He has worked in both academic and practical settings, contributing to groundbreaking research and high-impact projects that aim to mitigate environmental degradation. Awuor’s professional trajectory includes positions with leading international organizations, governmental agencies, and NGOs where he has used his expertise to shape environmental strategies, conduct assessments, and lead multidisciplinary teams. His ability to navigate complex environmental challenges and provide actionable solutions has earned him a solid reputation within his field. His role in guiding projects that focus on climate adaptation, conservation strategies, and environmental sustainability underscores his significant contribution to the sector.

Research Interests

Silas Onyango Awuor’s research interests are vast and multidisciplinary, focusing on the intersection of environmental science, climate change, sustainable development, and community engagement. His work often explores how human activities interact with natural ecosystems and the long-term impacts of these interactions. He is particularly interested in studying the effects of climate change on vulnerable ecosystems and communities, with a focus on adaptation strategies. His research also encompasses biodiversity conservation, ecosystem services, environmental governance, and sustainable land use practices. Awuor has an enduring passion for identifying practical solutions that can be implemented at both local and global levels to address environmental issues. His work aims to bridge the gap between scientific research and policy, providing evidence-based recommendations for sustainable development.

Research Skills

Awuor possesses a diverse set of research skills that have contributed to his success in the environmental science field. His expertise spans a range of research methodologies, including fieldwork, data collection and analysis, and the use of advanced modeling techniques for assessing environmental impacts. Awuor is skilled in GIS (Geographic Information Systems), remote sensing, environmental impact assessments (EIA), and environmental policy analysis. His ability to integrate social science methodologies with natural science approaches has been key in addressing the human dimensions of environmental challenges. Furthermore, Awuor has extensive experience working with interdisciplinary teams, synthesizing complex datasets, and translating research findings into actionable policy recommendations. His focus on community-based research further highlights his skills in understanding the social and cultural contexts of environmental problems.

Awards and Honors

Silas Onyango Awuor has been recognized for his excellence in the field of environmental science and sustainable development. His contributions to environmental research, policy development, and community engagement have earned him several prestigious awards and honors. These accolades include recognition from academic institutions, government agencies, and international organizations, underscoring his impact on advancing global environmental strategies. His awards reflect his leadership in environmental conservation, his innovative approach to sustainability, and his dedication to improving the lives of vulnerable populations affected by climate change. Awuor’s commitment to excellence and his influential role in the environmental science community have been consistently acknowledged throughout his career.

Conclusion

In conclusion, Silas Onyango Awuor is a distinguished environmental scientist with a wealth of knowledge, expertise, and experience in addressing some of the most pressing environmental challenges of our time. Through his research, professional roles, and leadership, he has contributed significantly to the advancement of sustainable development practices, climate adaptation strategies, and environmental policy formulation. Awuor’s work is a testament to the importance of interdisciplinary collaboration and community-focused solutions in the pursuit of environmental justice and sustainability. As he continues to shape the future of environmental science, Awuor remains a valuable asset to the global environmental movement, inspiring future generations to engage with and protect the planet.

Publication Top Notes

  • Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya
    • Authors: SO Awuor, EO Omwenga, II Daud
    • Journal: African Journal of Primary Health Care and Family Medicine
    • Year: 2020
    • Citations: 16
  • Cholera outbreak: antibiofilm activity, profiling of antibiotic-resistant genes and virulence factors of toxigenic Vibrio cholerae isolates reveals concerning traits
    • Authors: SO Awuor, EO Omwenga, RM Mariita, II Daud
    • Journal: Access Microbiology
    • Year: 2022
    • Citations: 13
  • Morphological patterns of anemia among under five children on Prevention of Mother-To-Child Transmission (PMTCT) programmes in Masogo sub-county hospital, Kisumu county, Kenya
    • Authors: SO Awuor, OO Eric, S Musyoki, II Daud, RO Nyangaresi, P Mugah, …
    • Journal: medRxiv
    • Year: 2021
    • Citations: 5
  • Monitoring the battleground: exploring antimicrobial resistance and virulence factors in wound bacterial isolates
    • Authors: SO Awuor, EO Omwenga, RM Mariita, JM Musila, S Musyoki
    • Journal: Access Microbiology
    • Year: 2023
    • Citations: 3
  • Incidence, antifungal resistance properties, and virulence traits of candida species isolated from HIV/AIDS Patients from the hospital system in Kenya
    • Authors: Haron Nyaboga Miruka, OO Eric, S Musyoki, SO Awuor
    • Journal: Access Microbiology
    • Year: 2023
    • Citations: 2
  • Monitoring the battleground: antimicrobial resistance, antibiofilm patterns, and virulence factors of wound bacterial isolates from patients in hospital system
    • Authors: SO Awuor, R Mariita, EO Omwenga, J Musila, S Musyoki
    • Journal: medRxiv
    • Year: 2023
    • Citations: 2
  • Prevalence of Pregnancy among Adolescent Living with HIV in Muhoroni Sub County Kisumu County, Kenya
    • Author: SO Awuor
    • Journal: International Journal of Anesthesia and Clinical Medicine
    • Year: 2021
    • Citations: 2
  • Monitoring the battlefield: Antimicrobial resistance, antibiofilm patterns and virulence factors of Acinetobacter baumannii isolates from hospital system
    • Author: SO Awuor
    • Journal: bioRxiv
    • Year: 2022
    • Citations: 1
  • Incidence, antifungal resistance properties, and virulence traits of candida species isolated from HIV/AIDS patients from county hospitals in Kenya
    • Authors: H Miruka, EO Omwenga, S Musyoki, SO Awuor
    • Journal: PAMJ-One Health
    • Year: 2024
  • Global Health Alert: Racing to Control Antimicrobial-Resistant Candida auris and Healthcare Waste Disinfection Using UVC LED Technology
    • Authors: JM Reedy, T Fernando, SO Awuor, EO Omwenga, T Koutchma, …
    • Journal: Hygiene
    • Year: 2024

 

De-Wei Lai | Microbiology | Best Scholar Award

Prof. Dr. De-Wei Lai | Microbiology | Best Scholar Award

Associate Researcher at Taichung Veterans General Hospital, Taiwan

Dr. De-Wei Lai is an accomplished Associate Researcher at the Department of Medical Research, Taichung Veterans General Hospital, Taiwan. With a strong foundation in applied chemistry and immunology, he has dedicated his career to unraveling the complexities of regulatory T cells in diverse pathological conditions. Dr. Lai’s research spans autoimmunity, regenerative medicine, and the tumor microenvironment, with a focus on innovative immunotherapeutic strategies. His expertise integrates modern molecular techniques with natural extracts and traditional Chinese medicine, aiming to develop novel diagnostic and therapeutic solutions. With over 19 SCI/SCIE-indexed publications, 27 editorial appointments, and 16 awards, Dr. Lai has established himself as a leading voice in immunological research. His work, characterized by precision and translational potential, continues to shape the future of immunotherapy.

Professional Profile

Education

Dr. De-Wei Lai completed his undergraduate studies in Applied Chemistry at National Pingtung University, where he developed a deep interest in cellular metabolism and biochemical signaling pathways. He later pursued a Ph.D. in Immunology, focusing on the molecular mechanisms underlying diabetic retinopathy, which culminated in a groundbreaking publication in Circulation Research. His academic journey is marked by excellence in understanding complex immunological pathways and leveraging this knowledge for practical medical applications.

Professional Experience

Dr. Lai began his research career in 2019 at Chang Bing Show Chwan Memorial Hospital, where he studied the isolation, cultivation, and functional analysis of regulatory T cells (Tregs). His work laid the foundation for significant advancements in immunotherapy. In 2024, he joined Taichung Veterans General Hospital, where he expanded his focus to include molecular mechanisms of Tregs in autoimmune diseases, regenerative medicine, and tumor microenvironments. Throughout his career, Dr. Lai has consistently contributed to high-impact research, addressing critical gaps in clinical immunology and advancing innovative therapeutic strategies.

Research Interests

Dr. Lai’s research interests lie at the intersection of immunotherapy, molecular biology, and regenerative medicine. His laboratory explores the molecular mechanisms of regulatory T cells in autoimmune diseases, age-related degenerative conditions, and cancer. Recently, Dr. Lai has extended his work to study the potential of natural extracts, traditional Chinese medicine, and metal-organic nanoparticles as modulators of the immune system. By integrating experimental models with clinical big data, his research aims to develop novel diagnostic tools and immunotherapeutic strategies that address pressing medical challenges.

Research Skills

Dr. Lai possesses a robust skill set in immunological research and molecular biology. His expertise includes regulatory T cell isolation and expansion, animal model development for autoimmune diseases, and the study of tumor microenvironments. He is proficient in advanced techniques such as flow cytometry, immunohistochemistry, and molecular signaling analysis. His interdisciplinary approach also incorporates the evaluation of natural compounds and nanoparticles for therapeutic applications. With strong analytical skills and an eye for innovation, Dr. Lai excels in bridging basic research with translational medicine.

Awards and Honors

Dr. Lai’s contributions to immunological research have been widely recognized. He has received 16 awards and recognitions, highlighting his impact in both academic and clinical settings. These honors reflect his groundbreaking discoveries in T cell biology, innovative therapeutic approaches, and commitment to advancing immunotherapy. His editorial appointments in 27 journals and conferences further underscore his standing in the scientific community as a trusted authority in immunological research. Dr. Lai’s dedication to addressing clinical challenges continues to earn him accolades and inspire future research efforts.

Conclusion

Dr. De-Wei Lai is an excellent candidate for the Best Scholar Award due to his exceptional research achievements, dedication to addressing clinical challenges, and innovative approach to immunotherapy. While he excels in academic publication and editorial roles, areas like project leadership, patents, and international collaborations offer room for growth. Overall, his contributions to immunology and translational medicine make him a strong contender for this recognition.

Publications Top Notes

  • Melatonin set out to ER stress signaling thwarts epithelial mesenchymal transition and peritoneal dissemination via calpain‐mediated C/EBP β and NF κ B cleavage
    • Authors: SM Wu, WY Lin, CC Shen, HC Pan, W Keh‐Bin, YC Chen, YJ Jan, DW Lai, …
    • Journal: Journal of Pineal Research, 60 (2), 142-154
    • Year: 2016
    • Citations: 98
  • Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress, and inhibiting epithelial-to-mesenchymal transition
    • Authors: SH Liu, WJ Lee, DW Lai, SM Wu, CY Liu, HR Tien, CS Chiu, YC Peng, …
    • Journal: Molecular Oncology, 9 (4), 834-849
    • Year: 2015
    • Citations: 64
  • Honokiol thwarts gastric tumor growth and peritoneal dissemination by inhibiting Tpl2 in an orthotopic model
    • Authors: HC Pan, DW Lai, KH Lan, CC Shen, SM Wu, CS Chiu, KB Wang, …
    • Journal: Carcinogenesis, 34 (11), 2568-2579
    • Year: 2013
    • Citations: 45
  • Aryl hydrocarbon receptor deficiency attenuates oxidative stress-related mesangial cell activation and macrophage infiltration and extracellular matrix accumulation in diabetic nephropathy
    • Authors: WJ Lee, SH Liu, CK Chiang, SY Lin, KW Liang, CH Chen, HR Tien, …
    • Journal: Antioxidants & Redox Signaling, 24 (4), 217-231
    • Year: 2016
    • Citations: 44
  • The novel Aryl hydrocarbon receptor inhibitor biseugenol inhibits gastric tumor growth and peritoneal dissemination
    • Authors: DW Lai, SH Liu, AI Karlsson, WJ Lee, KB Wang, YC Chen, CC Shen, …
    • Journal: Oncotarget, 5 (17), 7788
    • Year: 2014
    • Citations: 43
  • Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways
    • Authors: CS Chiu, CH Tsai, MS Hsieh, SC Tsai, YJ Jan, WY Lin, DW Lai, SM Wu, …
    • Journal: Cancer Letters, 442, 113-125
    • Year: 2019
    • Citations: 42
  • TPL2 (therapeutic targeting tumor progression locus-2)/ATF4 (activating transcription factor-4)/SDF1α (chemokine stromal cell-derived factor-α) axis suppresses diabetic retinopathy
    • Authors: DW Lai, KH Lin, WHH Sheu, MR Lee, CY Chen, WJ Lee, YW Hung, …
    • Journal: Circulation Research, 121 (6), e37-e52
    • Year: 2017
    • Citations: 37
  • Attenuation of in vitro and in vivo melanin synthesis using a Chinese herbal medicine through the inhibition of tyrosinase activity
    • Authors: SC Liu, ML Sheu, YC Tsai, YC Lin, CW Chang, DW Lai
    • Journal: Phytomedicine, 95, 153876
    • Year: 2022
    • Citations: 22
  • Melatonin protects retinal integrity through mediated immune homeostasis in the sodium iodate-induced mouse model of age-related macular degeneration
    • Authors: LC Ku, ML Sheu, HH Cheng, CY Lee, YC Tsai, CY Tsai, KH Lin, LC Lai, …
    • Journal: Biomedicine & Pharmacotherapy, 161, 114476
    • Year: 2023
    • Citations: 10
  • AHR/TET2/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression
    • Authors: HH Cheng, L Hung‐Ke, ML Sheu, CY Lee, YC Tsai, DW Lai
    • Journal: Immunology, 168 (4), 654-670
    • Year: 2023
    • Citations: 8

 

Dhruvi Modi | microbiology | Best Researcher Award

Dr. Dhruvi Modi | microbiology | Best Researcher Award 

Research Coordinator at Albert Einstein College of Medicine, United States.

Dr. Dhruvi Modi, M.B.B.S., is a dedicated medical professional, certified by the ECFMG. She completed her M.B.B.S. from the Gujarat Adani Institute of Medical Sciences, Bhuj, India. Throughout her academic journey, Dr. Modi has gained experience through multiple internships and externships across prestigious medical institutions in India, the United States, and Canada. Notable for her contributions in the fields of cardiology, neurology, and infectious diseases, Dr. Modi is committed to expanding her expertise in healthcare. Currently, she is serving as an extern at Beaumont Medical Center and has gained recognition for her clinical skills and research contributions. She also contributes as an editor for Sudden Unexpected Death in Epilepsy books and reviews medical content for USMLE preparation. Dr. Modi aims to continuously enhance her knowledge and contribute meaningfully to the global medical community.

Profile

Education 🎓

Dr. Dhruvi Modi graduated with an M.B.B.S. degree from the Gujarat Adani Institute of Medical Sciences, Bhuj, India, in 2021. During her time there, she focused on acquiring a strong foundation in medicine and clinical practices. She completed her medical internship in various specialized departments at Gujarat Adani Institute and Surat Municipal Institute of Medical Education. Throughout her education, she developed a deep understanding of medical principles while engaging in clinical exposure and hands-on training. Dr. Modi also pursued multiple externships in institutions such as Beaumount Medical Center, Advent Health Orlando, and St. Mary Hospital in the United States, broadening her international exposure. These experiences provided her with diverse medical knowledge and a deep commitment to further education in the medical field, including ongoing training for USMLE exams and clinical shadowing.

Experience 💼

Dr. Dhruvi Modi has a robust background in clinical medicine, with experience in multiple prestigious medical settings. Her early experience included internships in India at Gujarat Adani Institute of Medical Sciences and Surat Municipal Institute of Medical Education, where she honed her skills in patient care, diagnosis, and treatment. Subsequently, she expanded her international medical expertise with externships at Beaumount Medical Center, Advent Health Orlando, and St. Mary Hospital in the United States, focusing on various specialties such as cardiology, neurology, and pulmonary medicine. Dr. Modi further enhanced her knowledge through externships in family medicine, emergency medicine, and cardiology, all while maintaining a strong academic record. Currently, she serves as an editor for books on Sudden Unexpected Death in Epilepsy and reviews content for USMLE preparation, showcasing her deep engagement with both medical practice and education.

Research Interests 🔬

Dr. Dhruvi Modi’s research interests primarily lie in cardiology, neurology, infectious diseases, and the impact of public health interventions. She has authored and contributed to several studies that investigate cardiovascular diseases, the effect of obesity on patient outcomes, and the relationship between body mass index and the prevalence of cardiovascular illnesses in the United States. Dr. Modi has shown a strong commitment to advancing knowledge in epidemiology, particularly through nationwide analysis and the application of artificial intelligence in predictive medical modeling. Her current research explores the effect of COVID-19 on hypertrophic cardiomyopathy and obesity in COVID-19 patients. Dr. Modi’s work aims to improve understanding of chronic diseases and contribute to better healthcare strategies globally, especially in underserved populations.

Awards 🏆

Dr. Dhruvi Modi’s dedication to medicine has earned her multiple accolades, including certifications and recognition for her performance in various fields. Her achievements include passing the USMLE Step 1 with a score of 236 and Step 2 with 235. She has been involved in numerous health initiatives, including UNICEF’s “Parvah” workshop and AMCON conferences, where she presented case reports on critical health topics. Dr. Modi’s commitment to community service is evident through her volunteer work with the WHO in Gujarat and participation in numerous health camps for underserved populations in India. She was also honored with opportunities to mentor students and conduct health checkups in collaboration with multiple medical organizations. These efforts underline her commitment to advancing healthcare and improving patient outcomes globally.

Publications 📚

Dr. Dhruvi Modi has contributed significantly to medical literature, with multiple published articles in prominent medical journals. Her most recent publication, titled “Prevalence of NAFLD and Associated Cardiovascular Events” (2023), was featured in the AGA Institute and presented at Digestive Day Week in Chicago. She has also authored articles on hypertrophic cardiomyopathy and the role of obesity in mortality among COVID-19 patients. Other notable works include her research on predictors of adverse cardiac and cerebrovascular events in inflammatory bowel disease, published in The American Journal of Gastroenterology (2023), and her systematic review on acute myocarditis, submitted to Cureus (2023). Dr. Modi’s research continues to be widely cited in medical journals, contributing to the growing body of knowledge in cardiology and public health.

  • Tu1603 Prevalence of NAFLD and Associated Cardiovascular Events and Prevailing Disparities in Otherwise Metabolically Healthy US Adults, 2019 National Inpatient Sample Analysis: A Paradox Effect
    Published: 2023
    Journal: AGA Institute Elsevier
    Volume: 164, Issue 6, Pages S-1054-S-1055
    Link: https://doi.org/10.1016/S00165085(23)03451-0
    Summary: This study analyzes the prevalence of non-alcoholic fatty liver disease (NAFLD) and its association with cardiovascular events in metabolically healthy individuals in the US, highlighting a paradoxical effect of NAFLD in a generally healthy cohort.
  • Examining the Effect of COVID-19 on Hypertrophic Cardiomyopathy Hospitalizations in the USA: A Nationwide Propensity-Score Matched Analysis
    Published: November 9, 2023
    Journal: European Journal of Cardiology
    Link: https://doi.org/10.1093/eurheartj/ehad655.2
    Summary: This research investigates the impact of the COVID-19 pandemic on the hospitalization rates of hypertrophic cardiomyopathy patients in the United States, offering insights into healthcare system responses and patient outcomes during the pandemic.
  • Predictors of Major Adverse Cardiac and Cerebrovascular Events in Inflammatory Bowel Disease Using Artificial Neural Network Analysis in a Nationally Representative US Cohort
    Published: July 2023
    Journal: The American Journal of Gastroenterology
    Volume: 118(10S), Pages S669-S670
    Link: https://doi.org/10.14309/01.ajg.0000953236.08480.f1
    Summary: This study uses advanced artificial neural network models to predict the likelihood of major adverse cardiac and cerebrovascular events in patients with inflammatory bowel disease, providing valuable insights into the management of comorbidities in this patient group.

Conclusion

Dr. Dhruvi Modi exhibits exceptional promise as a researcher and clinician. Her robust background in medical internships, externships, and volunteer roles, along with her impressive publication record in well-known journals, makes her highly deserving of the Research for Best Researcher Award. Her work demonstrates a unique blend of clinical expertise and research capability, contributing to significant advances in various medical fields. With a slight increase in interdisciplinary research and expanded global collaborations, she has the potential to make even more groundbreaking contributions to healthcare research.

 

Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Prof. Han Young Chung | Pathogenic Microbiology | Best Researcher Award

Associate Professor at Chungnam National University/College of Pharmacy, South Korea

Dr. Han Young Chung is an accomplished Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. With a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University, Dr. Chung has an extensive background in gastroenterology research, having completed post-doctoral fellowships at The University of Michigan and Seoul National University. He has received multiple honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and several prestigious scholarships. Dr. Chung has successfully secured research funding, notably leading a Creative Challenge Project funded by the National Research Foundation of Korea. His prolific publication record includes numerous articles in high-impact journals, focusing on food safety and pathogenic microorganisms. He has also presented his research internationally, contributing to advancements in understanding microbial interactions and pathogenesis. Dr. Chung’s dedication to research and teaching makes him a strong candidate for the Best Researcher Award.

Profile

Education

Dr. Han Young Chung has an impressive educational background that underpins his expertise in the field of molecular microbiology and toxicology. He completed his Bachelor’s degree in Biotechnology and Bioinformatics, graduating cum laude from Korea University in 2013, where he achieved an overall GPA of 4.4/4.5. Following this, he pursued his Ph.D. at Seoul National University, where he specialized in Molecular Microbiology and Toxicology. Dr. Chung excelled in his studies, earning a remarkable overall GPA of 4.11/4.3 while completing 60 credits from September 2013 to August 2020. After obtaining his doctorate, he enhanced his research experience as a Post-Doctoral Fellow at the University of Michigan Medical School from September 2022 to February 2024 and previously at the Center for Food and Bioconvergence at Seoul National University. His educational journey reflects a strong foundation in scientific research and dedication to advancing knowledge in his field.

Professional Experience

Dr. Han Young Chung is currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University in South Korea since March 2024. Prior to this role, he was a Post-Doctoral Fellow in the Division of Gastroenterology at the University of Michigan Medical School from September 2022 to February 2024. Dr. Chung also held the position of Research Assistant Professor at the Center for Food and Bioconvergence, Seoul National University (SNU), from June 2021 to August 2022, after completing another Post-Doctoral Fellowship at SNU from September 2020 to May 2021. His academic journey began with a Ph.D. in Molecular Microbiology and Toxicology from SNU (2013-2020) and a Bachelor’s degree in Biotechnology and Bioinformatics from Korea University (2009-2013). Throughout his career, Dr. Chung has contributed significantly to the fields of microbiology and toxicology, demonstrating a strong commitment to research and education.

Research Interest

Dr. Han Young Chung’s research interests lie at the intersection of molecular microbiology and toxicology, with a strong focus on food safety and pathogen virulence. His work explores the interactions between foodborne pathogens, such as Vibrio vulnificus and Staphylococcus aureus, and their impact on human health, particularly in relation to thrombosis and other adverse health outcomes. Dr. Chung employs advanced genomic and transcriptomic analyses to investigate the pathogenic mechanisms of these microbes, aiming to uncover insights that could enhance food safety measures. Additionally, he is interested in the role of nanomaterials, such as nanoplastics, in promoting coagulation and thrombus formation, which can have significant implications for public health. His interdisciplinary approach combines microbiology, toxicology, and bioinformatics, positioning him as a leader in research that addresses pressing issues in food safety and microbial pathogenesis.

Research Skills

Dr. Han Young Chung possesses a diverse and robust skill set in research, primarily focusing on molecular microbiology and toxicology. His expertise includes advanced techniques in genome and transcriptome analysis, enabling him to investigate the genetic makeup and pathogenicity of various microorganisms, particularly food-borne pathogens. He has significant experience in experimental design, data analysis, and interpretation, which he has demonstrated through numerous high-impact publications in reputable SCI journals. Dr. Chung is proficient in conducting in vitro and in vivo studies, utilizing cutting-edge methodologies such as nanotechnology and high-throughput sequencing. His ability to collaborate effectively with interdisciplinary teams has led to successful projects, including significant grants and innovative research initiatives. Furthermore, Dr. Chung’s strong presentation skills have enabled him to share his findings at international conferences, enhancing the visibility of his research and contributing to the global scientific community. Overall, his comprehensive research skills make him a valuable asset in the field.

Award and Recognition

Dr. Han Young Chung is a distinguished researcher currently serving as an Assistant Professor at the College of Pharmacy, Chungnam National University, South Korea. He holds a Ph.D. in Molecular Microbiology and Toxicology from Seoul National University and has completed post-doctoral fellowships at The University of Michigan Medical School and Seoul National University. Dr. Chung has received several honors, including the Best Presentation Award from the Korean Society for Microbiology and Biotechnology and the Best Performance Award during his undergraduate research program at Hanyang University. His research, which focuses on the pathogenesis of foodborne pathogens, has led to significant publications in high-impact journals, including Nature Communications and Particulate Science and Technology. Dr. Chung’s work has been supported by grants such as the National Research Foundation of Korea, underscoring his contribution to advancing scientific knowledge in his field. His innovative research and dedication make him a strong candidate for the Best Researcher Award.

Conclusion

Dr. Han Young Chung exemplifies the qualities of a leading researcher through his robust academic background, significant research contributions, and recognition in his field. His expertise in molecular microbiology and toxicology addresses critical issues in food safety and public health, making him a deserving candidate for the Best Researcher Award. By focusing on broader collaboration, mentorship, and public engagement, he can further enhance his impact in the scientific community and beyond. Recognizing his achievements with this award will not only honor his contributions but also inspire future researchers in the field.

Publication Top Notes
  • Loss of integrity: impairment of the blood-brain barrier in heavy metal-associated ischemic stroke
    • Authors: JH Kim, HM Byun, EC Chung, HY Chung, ON Bae
    • Year: 2013
    • Journal: Toxicological Research
    • Volume/Issue/Page: 29, 157-164
  • Analysis of microbiota on abalone (Haliotis discus hannai) in South Korea for improved product management
    • Authors: MJ Lee, JJ Lee, HY Chung, SH Choi, BS Kim
    • Year: 2016
    • Journal: International Journal of Food Microbiology
    • Volume/Issue/Page: 234, 45-52
  • Molecular interaction between methicillin-resistant Staphylococcus aureus (MRSA) and chicken breast reveals enhancement of pathogenesis and toxicity for food-borne outbreak
    • Authors: HY Chung, YT Kim, JG Kwon, HH Im, D Ko, JH Lee, SH Choi
    • Year: 2021
    • Journal: Food Microbiology
    • Volume/Issue/Page: 93, 103602
  • Rapid, simultaneous and nanomolar determination of pyroglutamic acid and cis-/trans-urocanic acid in human stratum corneum by hydrophilic interaction liquid chromatography …
    • Authors: KM Joo, JY Han, ED Son, GW Nam, HY Chung, HJ Jeong, JC Cho, …
    • Year: 2012
    • Journal: Journal of Chromatography B
    • Volume/Issue/Page: 897, 55-63
  • Amine-modified nanoplastics promote the procoagulant activation of isolated human red blood cells and thrombus formation in rats
    • Authors: EH Kim, S Choi, D Kim, HJ Park, Y Bian, SH Choi, HY Chung, ON Bae
    • Year: 2022
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 19(1), 60
  • Titanium dioxide nanoparticles enhance thrombosis through triggering the phosphatidylserine exposure and procoagulant activation of red blood cells
    • Authors: Y Bian, HY Chung, ON Bae, KM Lim, JH Chung, J Pi
    • Year: 2021
    • Journal: Particle and Fibre Toxicology
    • Volume/Issue/Page: 18, 1-12
  • Inhibitory effects of black soybean on platelet activation mediated through its active component of adenosine
    • Authors: K Kim, KM Lim, HJ Shin, DB Seo, JY Noh, S Kang, HY Chung, S Shin, …
    • Year: 2013
    • Journal: Thrombosis Research
    • Volume/Issue/Page: 131(3), 254-261
  • Complete genome sequence of Vibrio vulnificus FORC_017 isolated from a patient with a hemorrhagic rash after consuming raw dotted gizzard shad
    • Authors: HY Chung, YT Kim, S Kim, EJ Na, HJ Ku, KH Lee, ST Heo, S Ryu, H Kim, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Complete genome of Vibrio parahaemolyticus FORC014 isolated from the toothfish
    • Authors: S Ahn, HY Chung, S Lim, K Kim, S Kim, EJ Na, K Caetano-Anolles, …
    • Year: 2016
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 8, 1-6
  • Comparative genomic analysis reveals genetic features related to the virulence of Bacillus cereus FORC_013
    • Authors: HJ Koo, S Ahn, HY Chung, S Kim, K Kim, S Ryu, JH Lee, SH Choi, H Kim
    • Year: 2017
    • Journal: Gut Pathogens
    • Volume/Issue/Page: 9, 1-8

 

 

Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Ms. Wajiha Ahmed | Immunology and Microbiology | Women Researcher Award

Post Doctoral Fellow of Suzhou institute of Nano tech and Nano bionics, China.

Wajiha Ahmed is a distinguished researcher from Pakistan with a diverse background in biomaterials and biology. She earned her PhD from Zhejiang University, China, where she focused on immune regulation and wound healing using innovative biomaterials like chiral polymers and ROS-responsive nanofibers. Her Master’s research involved plant-derived silver nanoparticles for chemical sensing, showcasing her early commitment to impactful research. Wajiha’s significant contributions are reflected in her nine peer-reviewed publications in reputable journals, including ACS Biomaterials Science & Engineering and Journal of Biomedical Materials Research Part A. Currently serving as Assistant General Manager at Global Clinical Cura Pvt. Limited, she combines academic expertise with industry experience. Her research addresses critical health issues, particularly in wound healing for diabetic and infectious wounds, emphasizing her dedication to advancing medical science. Wajiha’s international experience and impactful research make her a strong candidate for the Best Researcher Award.

Profile
Education

Wajiha Ahmed’s educational journey reflects a strong foundation in biotechnology and biomedical sciences, coupled with advanced research experience in biomaterials. She earned her PhD from Zhejiang University, China, where she specialized in biomaterials with a focus on immune regulation and wound healing. Her doctoral research involved innovative projects such as developing ROS-responsive polymer nanofibers and exploring the impact of enantiomeric polylysine on inflammatory responses, showcasing her expertise in cutting-edge biomedical applications. Prior to her PhD, Wajiha completed her Master’s degree in Biomedical Sciences and Engineering from the National University of Sciences and Technology (NUST), Islamabad, Pakistan. Her Master’s thesis centered on the chemical sensing of carcinogens using plant-derived fluorescent flavonoids, demonstrating her ability to integrate biological and chemical sciences. Wajiha’s academic journey began with a Bachelor’s degree in Biotechnology from the Islamia University of Bahawalpur, Pakistan, where she gained a solid grounding in the life sciences.

Professional Experience

Wajiha Ahmed has a diverse professional background, blending academic and industry experience. She currently serves as the Assistant General Manager at Global Clinical Cura Pvt. Limited, a role she has held since January 2021, where she manages key clinical operations, contributing to the company’s strategic goals. Prior to this, Wajiha held academic positions, including as a Visiting Lecturer at Shifa Tameer-e-Millat University in Islamabad, Pakistan, from February 2016 to 2017, where she was involved in teaching and curriculum development. She also served as a Lecturer at Fazaia Intercollege Jinnah Camp in Islamabad from February 2016 to August 2017, and as a Teacher at Springfield Public School and College in Rawalpindi from March 2014 to 2015. These roles allowed her to hone her teaching skills and foster a deep commitment to education. Her professional experience reflects a solid foundation in both educational and managerial capacities.

Research Interest

Wajiha Ahmed’s research interests are deeply rooted in the interdisciplinary fields of biomaterials and biomedical engineering, with a particular focus on developing innovative solutions for wound healing and immune regulation. Her work spans the synthesis and characterization of advanced materials such as chiral polymers, ROS-responsive polymer nanofibers, and plant-derived silver nanoparticles. Wajiha is particularly interested in exploring the interactions between biomaterials and biological systems, aiming to enhance therapeutic outcomes in conditions such as diabetic wounds and chronic inflammations. Her PhD research on multifunctional drug-loaded nanofibers for smart wound healing and the immune modulation of bone marrow-derived macrophages highlights her dedication to addressing critical health challenges through material science. Additionally, her background in chemical sensing of carcinogens using plant-based materials underscores her commitment to environmental and health safety, making her research both impactful and socially relevant.

Research Skills

Wajiha Ahmed is an accomplished researcher with a robust set of skills in biomaterials and biomedical sciences. Her expertise lies in the synthesis and characterization of advanced nanomaterials, including chiral polymers and ROS-responsive polymer nanofibers, which she has applied to critical areas such as immune regulation and wound healing. Wajiha is proficient in various laboratory techniques, including nanoparticle synthesis, polymer grafting, and in vitro cellular assays. Her ability to design and conduct complex experiments is evident in her contributions to high-impact research projects. Additionally, she is skilled in data analysis and interpretation, employing advanced analytical tools to derive meaningful insights from experimental results. Wajiha’s research is also characterized by strong interdisciplinary collaboration, allowing her to integrate biological, chemical, and material science principles effectively. Her publications in reputable journals further reflect her dedication to advancing knowledge in the field of biomaterials.

 Awards and Recognition

Wajiha Ahmed has earned recognition for her exceptional contributions to the field of biomaterials and biology. Her innovative research on immune regulation, wound healing, and chemical sensing has been published in reputable journals, highlighting her impact on advancing scientific knowledge. Wajiha’s work has been acknowledged through her role as a first and co-author in multiple peer-reviewed publications, reflecting her dedication and expertise. Her international research experience, particularly during her PhD at Zhejiang University, has further solidified her reputation as a promising researcher in her field. Additionally, Wajiha’s involvement in interdisciplinary projects and her ability to address critical health challenges, such as diabetic wound healing, underscore her commitment to research that has tangible societal benefits. While she is still in the early stages of her career, her accomplishments have already positioned her as a rising star in biomaterials research, earning her respect and recognition among her peers.

Conclusion

Wajiha Ahmed is a strong candidate for the Best Researcher Award, given her significant contributions to biomaterials research, her impressive publication record, and her international research experience. To further strengthen her candidacy, she could focus on expanding her industrial collaborations and increasing her public engagement efforts. Overall, her multidisciplinary expertise and commitment to addressing societal challenges through research make her a suitable and competitive nominee for the award.

Publications Top Notes

  • Bi-layered Polyurethane Nanofiber Patches with Asymmetrical Surface Prevent Postoperative Adhesion and Enhance Cardiac Repair
    • Authors: Li, S., Ahmed, W., Wang, S., Zhu, Y., Gao, C.
    • Year: 2024
    • DOI: 10.1016/j.compositesb.2024.111668
  • Taking Chiral Polymers Toward Immune Regulation
    • Authors: Ahmed, W., Karabaliev, M., Gao, C.
    • Year: 2022
    • Citations: 6
    • DOI: 10.1002/pol.20220163
  • Influence of Enantiomeric Polylysine Grafted on Gold Nanorods on the Uptake and Inflammatory Response of Bone Marrow-Derived Macrophages in Vitro
    • Authors: Ahmed, W., Zhang, H., Gao, C.
    • Year: 2022
    • DOI: 10.1002/jbm.a.37068
  • Reactive Oxygen Species-Responsive and Scavenging Polyurethane Nanoparticles for Treatment of Osteoarthritis In Vivo
    • Authors: Zhang, H., Xiong, H., Ahmed, W., Fan, C., Gao, C.
    • Year: 2021
    • Citations: 39
    • DOI: 10.1016/j.cej.2020.128147
  • Adaptive Antibacterial Biomaterial Surfaces and Their Applications
    • Authors: Ahmed, W., Zhai, Z., Gao, C.
    • Year: 2019
    • Citations: 134
    • DOI: 10.1016/j.mtbio.2019.100017
  • Design and Applications of Cell-Selective Surfaces and Interfaces
    • Authors: Zhang, H., Zheng, X., Ahmed, W., Chen, Y., Gao, C.
    • Year: 2018
    • Citations: 35
    • DOI: 10.1021/acs.biomac.8b00492